7Baggers
 hlvx financials: income statement, balance sheet & cash flow  Stock Titan Tue, 24 Feb 2026 08:57:39 GMT
 net cash of hillevax from 2021 to 2024  Statista Thu, 12 Feb 2026 08:00:00 GMT
 hillevax to be acquired by xoma royalty  MSN Mon, 09 Feb 2026 13:06:11 GMT
 xoma royalty reports third quarter and year to date 2025  GlobeNewswire Wed, 12 Nov 2025 08:00:00 GMT

Hillevax Inc
(NASDAQ:HLVX) 

HLVX stock logo

HilleVax, Inc., a clinical-stage biopharmaceutical company, is focused on developing and commercializing novel vaccines. The company is headquartered in Boston, Massachusetts.

Founded: 2020
IPO Price: $17 (Apr 29, 2022)
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends